• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Health

The psychology behind why people will take horse paste, but not COVID vaccines

By
Sy Mukherjee
Sy Mukherjee
Down Arrow Button Icon
By
Sy Mukherjee
Sy Mukherjee
Down Arrow Button Icon
September 2, 2021, 5:30 PM ET

Say you’re in the midst of an unprecedented global pandemic. To protect yourself, you have a choice between vaccines that were tested on tens of thousands of people in rigorous clinical trials specifically for the purpose of combating COVID-19, or a decades-old drug like ivermectin that is most commonly known as a powerful parasite fighting treatment, often used for horses and livestock.

One option has been endorsed by scientists, regulators, academic institutions, public health experts, and government leaders alike and proved remarkably effective as vaccines have been doled out to billions of people across the world less than a year into the outbreak; the other has a handful of approved uses in humans but no robust clinical evidence that it works against coronavirus illness, a fact the aforementioned experts repeatedly raise while warning against its off-label use for COVID. Which one of these would you take? And, more importantly if you’re going the equine dewormer route, why?

It’s a head-scratcher as a small but growing number of Americans—many of them from the anti-vaxxer or vaccine skeptic crowd—have pushed demand for ivermectin prescriptions (and the version for animals) into high gear over the past few months. This medical counterculture harbors an abiding belief that the efficacy and safety of COVID vaccines is overblown as well as a mistrust of pharmaceutical companies, government officials, and media narratives around the pandemic. The politicization of COVID public health efforts certainly doesn’t help matters since ideology is one of the strongest indicators of whether or not someone is a COVID vaccine skeptic. There were usually about 3,600 ivermectin prescriptions issued weekly in the U.S. prior to the pandemic; by mid-August, that number had jumped to 88,000 per week.

This is despite the fact that the Food and Drug Administration (FDA), the World Health Organization (WHO), and the very maker of ivermectin itself, pharma giant Merck, have all urged people not to go out and take large amounts of a livestock-focused drug to stop the coronavirus given the sheer lack of evidence it works and the very real risks of overdoses and hospitalization (the WHO recommends against any type of COVID-related ivermectin use outside of a clinical trial). The FDA is a bit more blunt and points out that ivermectin isn’t even meant to fight viruses.

“FDA has not approved ivermectin for use in treating or preventing COVID-19 in humans. Ivermectin tablets are approved at very specific doses for some parasitic worms, and there are topical (on the skin) formulations for head lice and skin conditions like rosacea. Ivermectin is not an anti-viral (a drug for treating viruses),” the agency says, noting reports of more people landing in the hospital from ivermectin overdoses. (It turns out your typical human shouldn’t take similar doses of a treatment as what’s given to a 1,000 pound horse.)

Mistrust in institutions and mainstream narratives is nothing new among certain slices of the populace. But why pair that mistrust with advocating for a completely different drug? Scottish psychologist and public health communicator Stuart Ritchie, a lecturer at King’s College London, has a fairly simple assessment of what’s driving the current ivermectin frenzy, much like the clamoring over hydroxychloroquine, an unproven treatment for COVID touted by former President Donald Trump.

“The reason for the double-standard is obvious: contrarianism. Treatments such as ivermectin (and hydroxychloroquine and Vitamin D) have never had mainstream approval, or the nod from U.K. or U.S. medical regulators for their use against COVID,” he wrote in a recent column for the NewStatesman. “The contrarians can get excited about the apparently dramatic effects of ivermectin without having to agree with people they regard as wildly wrong on case rates, death rates, the effects of lockdowns, and so on. They also get to feel the frisson of telling the world that they know better: they have secret knowledge about a super-important treatment, and the blinkered medical community just won’t listen.”

Numerous studies delving into the psychology of vaccine skeptics pick up on this contrarian bent, including significant evidence that presenting facts and data to anti-vaxxers typically makes them double down on their scientifically invalidated positions. It turns out that same quirk of psychology can also lead some people to champion an obscure animal drug in an act of epistemological defiance, especially when they can point to validation from politically charged organizations like America’s Frontline Doctors and the social media feeds of like-minded people.

The ivermectin-for-coronavirus crowd is still a pretty small slice of the population. But it’s a vocal one with the ability to reach millions of people via social media and drive unnecessary hospitalizations from overdoses in a moment when ICUs are already at the breaking point from treating COVID patients.

Subscribe to Fortune Daily to get essential business stories straight to your inbox each morning.

About the Author
By Sy Mukherjee
See full bioRight Arrow Button Icon

Latest in Health

Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025

Most Popular

Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • World's Most Admired Companies
  • See All Rankings
  • Lists Calendar
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

Latest in Health

Evacuations begin for hantavirus-hit cruise ship, with American passengers to be quarantined in Nebraska. ‘This is not another COVID’
HealthHealth
Evacuations begin for hantavirus-hit cruise ship, with American passengers to be quarantined in Nebraska. ‘This is not another COVID’
By Iain Sullivan, Suman Naishadham and The Associated PressMay 10, 2026
8 hours ago
joaquin
Commentary250 Years of Innovation
Johnson & Johnson CEO: America’s innovation advantage starts with health 
By Joaquin DuatoMay 9, 2026
2 days ago
You’re probably safe from the Hantavirus outbreak, but here’s what you absolutely must not do, experts say
PoliticsCoronavirus
You’re probably safe from the Hantavirus outbreak, but here’s what you absolutely must not do, experts say
By Catherina GioinoMay 8, 2026
2 days ago
The Best Online Personal Trainers of 2026: In-Depth Workout Coaching at Home
HealthDietary Supplements
The Best Online Personal Trainers of 2026: In-Depth Workout Coaching at Home
By Emily PharesMay 8, 2026
2 days ago
naomi
Commentarymental health
Naomi Osaka: the things I didn’t do to succeed
By Naomi OsakaMay 8, 2026
3 days ago
collins
PoliticsElections
73-year-old Susan Collins has been a senator for decades. She only just disclosed a benign essential tremor
By Patrick Whittle, Kimberlee Kruesi and The Associated PressMay 7, 2026
3 days ago

Most Popular

‘This is the way’: Elon Musk endorses Warren Buffett’s famed 5-minute plan to fix the national debt
Economy
‘This is the way’: Elon Musk endorses Warren Buffett’s famed 5-minute plan to fix the national debt
By Jacqueline MunisMay 10, 2026
14 hours ago
OpenAI CEO Sam Altman says Gen Z and millennials are using ChatGPT like a 'life advisor'—but college students might be one step ahead
Tech
OpenAI CEO Sam Altman says Gen Z and millennials are using ChatGPT like a 'life advisor'—but college students might be one step ahead
By Sydney LakeMay 10, 2026
14 hours ago
'Employers are increasingly turning to degree and GPA' in hiring: Recruiters retreat from ‘talent is everywhere,’ double down on top colleges
Future of Work
'Employers are increasingly turning to degree and GPA' in hiring: Recruiters retreat from ‘talent is everywhere,’ double down on top colleges
By Jake AngeloMay 9, 2026
2 days ago
Red flag test: former CEO explains why he rejects job candidates who say they can start right away
Success
Red flag test: former CEO explains why he rejects job candidates who say they can start right away
By Orianna Rosa RoyleMay 9, 2026
2 days ago
Ted Cruz says the quiet part out loud: Trump accounts are Social Security personal accounts as GOP senator reveals 'dirty little secret'
Politics
Ted Cruz says the quiet part out loud: Trump accounts are Social Security personal accounts as GOP senator reveals 'dirty little secret'
By Jason MaMay 9, 2026
1 day ago
Trump thinks he's flying to Beijing with leverage. China spent 6 years making sure he doesn't have any
Commentary
Trump thinks he's flying to Beijing with leverage. China spent 6 years making sure he doesn't have any
By Steve H. HankeMay 10, 2026
16 hours ago

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.